Skip to main content
. 2024 Apr 17;8(12):3001–3012. doi: 10.1182/bloodadvances.2023011626

Table 2.

ORRs

HCT (n = 14) SOT (n = 12) Total (N = 26)
Best overall response, n (%)
 CR 4 (28.6) 6 (50.0) 10 (38.5)
 PR 3 (21.4) 4 (33.3) 7 (26.9)
 SD 2 (14.3) 1 (8.3) 3 (11.5)
 PD 4 (28.6) 1 (8.3) 5 (19.2)
 NE 1 (7.1) 0 1 (3.8)
Responders, n (%) 7 (50.0) 10 (83.3) 17 (65.4)
 95% CI 23.0-77.0 51.6-97.9 44.3-82.8

A patient is considered a responder if the best overall response is either CR or PR.

NE, not evaluable; PD, progressive disease.

No disease assessment obtained.